RT Journal Article
SR Electronic
T1 COVID-19 epidemic: Power law spread and flattening of the curve
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.02.20051680
DO 10.1101/2020.04.02.20051680
A1 Verma, Mahendra K.
A1 Asad, Ali
A1 Chatterjee, Soumyadeep
YR 2020
UL http://medrxiv.org/content/early/2020/04/06/2020.04.02.20051680.abstract
AB In this letter we analyze the real-time infection data of COVID-19 epidemic for nine nations. We observe that till 27 March 2020, the number of infected individuals (I(t)) in USA, Spain, Germany, Iran, France, and India are growing exponentially. On the contrary, I(t) curves for China and South Korea exhibits power law behavior before flattening of the curve. The derivative İ (t), which is also the daily infection count, is proportional to I(t) for the exponential regime, but not for the power law regime. These valuable indicators could be used for epidemic forecast. We also argue that long-term community transmission and/or the transmission by asymptomatic carriers traveling long distances may be inducing the power law growth of the epidemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAli Asad is supported by Indo-French (CEFIPRA) project 6104-1, and Soumyadeep Chatterjee is supported by INSPIRE fellow- ship (IF180094) of Department of Science & Technology, India. Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe used the data given publicly on WorldOMeter, URL https://www.worldometers.info/ coronavirus/.